logo

For the Inventor, By the Inventor

Berlin, Germany

Glycotope Gmbh


USPTO Granted Patents = 26

% Expired Patents = 42.3



Trademarks = 2

Forward Citations = 93

Loading Chart...
Loading Chart...

28 inventors (with patents filed for the assignee):

goldMedal Steffen Goletz (22 out of 25 patents)

silverMedal Antje Danielczyk (10 out of 16 patents)

bronzeMedal Renate Stahn (6 out of 8 patents)

4.  Uwe Karsten (6 out of 9 patents)

5.  Lars Stöckl (5 out of 6 patents)

6.  Hans Baumeister (5 out of 6 patents)

7.  Philippe Ulsemer (3 out of 3 patents)

8.  Anja Löffler (3 out of 3 patents)

9.  Frederick Gyapon Quast (2 out of 3 patents)

10.  Jan Susan Rosenbaum (2 out of 12 patents)

11.  Matthias Kaup (2 out of 3 patents)

12.  Lars Stoeckl (2 out of 2 patents)

13.  Rik J Scheper (2 out of 2 patents)

14.  Alan Masterson (2 out of 2 patents)

15.  Herbert M Pinedo (2 out of 2 patents)


26 patents:

1. 12391956 - Methods, compositions and cells for preparing surfactant protein D (SP-D) (2025-08-19),
2. 12297289 - Anti-MUC1 antibody (2025-05-13),
3. 10752914 - Methods, compositions and cells for preparing surfactant protein D (SP-D) (2020-08-25),
4. 10280230 - Use of human cells of myeloid leukemia origin for expression of antibodies (2019-05-07),
5. 10184135 - Eukaryotic expression vectors comprising regulatory elements of the globin gene clusters (2019-01-22),
6. 9845361 - Recognition molecules for the treatment and detection of tumors (2017-12-19),
7. 9700610 - Microorganisms carrying a tumor antigen (2017-07-11),
8. 9527899 - Recombinant human follicle-stimulating hormone (2016-12-27),
9. 9494587 - Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates (2016-11-15),
10. 9487567 - Method for the production of an immunostimulating mucin (MUC1) (2016-11-08),
11. 9359439 - Fab-glycosylated antibodies (2016-06-07),
12. 9359427 - Methods for culturing human myeloid leukaemia cells and cells derived therefrom (2016-06-07),
13. 9217038 - MUC1 antibodies (2015-12-22),
14. 9051370 - Humanized EGFR antibodies (2015-06-09),
15. 9051356 - Use of human cells of myeloid leukaemia origin for expression of antibodies (2015-06-09),
Glycotope GmbH is a biotechnology company specializing in the development and production of innovative glycobiology-based therapeutics. They utilize their expertise in glycoengineering to create highly specific and effective drugs for the treatment of cancer and other diseases. Through their advanced technologies, Glycotope aims to improve patient outcomes and contribute to the advancement of precision medicine.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Glycotope Gmbh
26 Patents

#39 in D-1000 Berlin

#1,782 in Germany

#24,724 in the World

Berlin, DE
Berlin, Germany

Glycotope Gmbh

Forward Citations = 93

28 inventors:

goldMedal Steffen Goletz (22 out of 25 patents)

silverMedal Antje Danielczyk (10 out of 16 patents)

bronzeMedal Renate Stahn (6 out of 8 patents)

4.  Uwe Karsten (6 out of 9 patents)

5.  Lars Stöckl (5 out of 6 patents)

Please report any incorrect information to [email protected]
Loading…